Akoya Biosciences Inc (AKYA) — Financial Flexibility Index
Akoya Biosciences Inc (AKYA) has a Financial Flexibility Index of -0.06x as of March 2025. Free cash flow of $-7.01 Million (operating CF $-7.21 Million minus capex $204.00K) represents 0% of total liabilities ($118.54 Million). Also explore Akoya Biosciences Inc annual equity growth to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Akoya Biosciences Inc Financial Flexibility Index (2019–2024)
Historical Financial Flexibility Index trend for Akoya Biosciences Inc across 6 annual periods. Check strategic asset allocation of Akoya Biosciences Inc to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Akoya Biosciences Inc (2019–2024)
Year-by-year free cash flow to debt coverage for Akoya Biosciences Inc. For the full company profile including market capitalisation, see Akoya Biosciences Inc (AKYA) total market value.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -0.35x | $-41.65 Million | $-44.10 Million | $117.41 Million | ▲ +5.0% |
| 2023 | -0.37x | $-47.25 Million | $-50.90 Million | $126.60 Million | ▲ +5.0% |
| 2022 | -0.39x | $-46.14 Million | $-53.50 Million | $117.45 Million | ▲ +11.8% |
| 2021 | -0.45x | $-30.97 Million | $-36.07 Million | $69.56 Million | ▼ -641.6% |
| 2020 | -0.06x | $-3.55 Million | $-6.84 Million | $59.09 Million | ▲ +34.2% |
| 2019 | -0.09x | $-10.91 Million | $-13.78 Million | $119.57 Million | — |